Showing results 1 to 4 of 4
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Bepirovirsen (GSK3228836) in chronic hepatitis B infection: an evaluation of phase II progress Journal:Expert Opinion on Investigational Drugs | 30-Oct-2023 | ||
FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways Journal:Hepatology Communications | 7-Dec-2023 | ||
Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver‐related mortality in patients with diabetes Journal:Glycaemic control is a modifiable risk factor for hepatocellular carcinoma and liver-related mortality in patients with diabetes | 1-Nov-2024 | ||
| 3-Apr-2024 |